Gladius Capital Management LP Taro Pharmaceutical Industries LTD Transaction History

Gladius Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$0.0 - $42.97 $0 - $1,933	-45 Reduced 5.58%	761 $0
Q1 2024 May 14, 2024	SELL	$40.97 - $43.33 $3,113 - $3,293	-76 Reduced 8.62%	806 $34,000
Q4 2023 Feb 07, 2024	BUY	$32.77 - $42.31 $2,490 - $3,215	76 Added 9.43%	882 $36,000
Q3 2023 Dec 18, 2023	BUY	$35.46 - $40.13 $3,333 - $3,772	94 Added 13.2%	806 $30,000
Q3 2023 Oct 10, 2023	BUY	$35.46 - $40.13 $3,333 - $3,772	94 Added 13.2%	806 $31,000
Q2 2023 Dec 18, 2023	SELL	$24.24 - $40.97 $2,278 - $3,851	-94 Reduced 11.66%	712 $27,000
Q2 2023 Aug 08, 2023	BUY	$24.24 - $40.97 $17,258 - $29,170	712 New	712 $28,000

693K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Gladius Capital Management LP with notifications on news.